Literature DB >> 19555648

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake.

Shaomin Li1, Soyon Hong, Nina E Shepardson, Dominic M Walsh, Ganesh M Shankar, Dennis Selkoe.   

Abstract

In Alzheimer's disease (AD), the impairment of declarative memory coincides with the accumulation of extracellular amyloid-beta protein (Abeta) and intraneuronal tau aggregates. Dementia severity correlates with decreased synapse density in hippocampus and cortex. Although numerous studies show that soluble Abeta oligomers inhibit hippocampal long-term potentiation, their role in long-term synaptic depression (LTD) remains unclear. Here, we report that soluble Abeta oligomers from several sources (synthetic, cell culture, human brain extracts) facilitated electrically evoked LTD in the CA1 region. Abeta-enhanced LTD was mediated by mGluR or NMDAR activity. Both forms of LTD were prevented by an extracellular glutamate scavenger system. Abeta-facilitated LTD was mimicked by the glutamate reuptake inhibitor TBOA, including a shared dependence on extracellular calcium levels and activation of PP2B and GSK-3 signaling. In accord, synaptic glutamate uptake was significantly decreased by soluble Abeta. We conclude that soluble Abeta oligomers perturb synaptic plasticity by altering glutamate recycling at the synapse and promoting synapse depression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555648      PMCID: PMC2702854          DOI: 10.1016/j.neuron.2009.05.012

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  66 in total

1.  Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression.

Authors:  Wade Morishita; Wei Lu; Gordon B Smith; Roger A Nicoll; Mark F Bear; Robert C Malenka
Journal:  Neuropharmacology       Date:  2006-08-08       Impact factor: 5.250

2.  Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

Authors:  Pascale N Lacor; Maria C Buniel; Paul W Furlow; Antonio Sanz Clemente; Pauline T Velasco; Margaret Wood; Kirsten L Viola; William L Klein
Journal:  J Neurosci       Date:  2007-01-24       Impact factor: 6.167

Review 3.  Synaptic plasticity: multiple forms, functions, and mechanisms.

Authors:  Ami Citri; Robert C Malenka
Journal:  Neuropsychopharmacology       Date:  2007-08-29       Impact factor: 7.853

4.  Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway.

Authors:  Matthew Townsend; Tapan Mehta; Dennis J Selkoe
Journal:  J Biol Chem       Date:  2007-09-13       Impact factor: 5.157

5.  Beta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3beta, and PTEN.

Authors:  Melissa Nassif; Juliana Hoppe; Katiane Santin; Rudimar Frozza; Lauren L Zamin; Fabrício Simão; Ana P Horn; Christianne Salbego
Journal:  Neurochem Int       Date:  2006-10-02       Impact factor: 3.921

6.  AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

Authors:  Helen Hsieh; Jannic Boehm; Chihiro Sato; Takeshi Iwatsubo; Taisuke Tomita; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2006-12-07       Impact factor: 17.173

7.  Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

Authors:  A Y Hsia; E Masliah; L McConlogue; G Q Yu; G Tatsuno; K Hu; D Kholodenko; R C Malenka; R A Nicoll; L Mucke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

9.  Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.

Authors:  C P Jacob; E Koutsilieri; J Bartl; E Neuen-Jacob; T Arzberger; N Zander; R Ravid; W Roggendorf; P Riederer; E Grünblatt
Journal:  J Alzheimers Dis       Date:  2007-03       Impact factor: 4.472

10.  LTP inhibits LTD in the hippocampus via regulation of GSK3beta.

Authors:  Stéphane Peineau; Changiz Taghibiglou; Clarrisa Bradley; Tak Pan Wong; Lidong Liu; Jie Lu; Edmond Lo; Dongchuan Wu; Emilia Saule; Tristan Bouschet; Paul Matthews; John T R Isaac; Zuner A Bortolotto; Yu Tian Wang; Graham L Collingridge
Journal:  Neuron       Date:  2007-03-01       Impact factor: 17.173

View more
  400 in total

1.  Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.

Authors:  Santiago V Salazar; Timothy O Cox; Suho Lee; A Harrison Brody; Annabel S Chyung; Laura T Haas; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2018-12-05       Impact factor: 6.167

2.  PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity.

Authors:  Yifan Yu; Teresa Niccoli; Ziyu Ren; Nathaniel S Woodling; Benjamin Aleyakpo; Gyorgy Szabadkai; Linda Partridge
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

3.  Preparation and characterization of toxic Abeta aggregates for structural and functional studies in Alzheimer's disease research.

Authors:  Asad Jan; Dean M Hartley; Hilal A Lashuel
Journal:  Nat Protoc       Date:  2010-06-03       Impact factor: 13.491

Review 4.  Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.

Authors:  Peter Penzes; Jon-Eric Vanleeuwen
Journal:  Brain Res Rev       Date:  2011-01-26

Review 5.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

6.  Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice.

Authors:  Tao Ma; Xueliang Du; Joseph E Pick; Guangzhi Sui; Michael Brownlee; Eric Klann
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

7.  Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.

Authors:  Jason K Clark; Matthew Furgerson; Jonathon D Crystal; Marcus Fechheimer; Ruth Furukawa; John J Wagner
Journal:  Neurobiol Learn Mem       Date:  2015-09-15       Impact factor: 2.877

Review 8.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 9.  The neurodegeneration in Alzheimer disease and the prion protein.

Authors:  Gianluigi Forloni; Alessandra Sclip; Tiziana Borsello; Claudia Balducci
Journal:  Prion       Date:  2013-01-01       Impact factor: 3.931

10.  Pin1 mediates Aβ42-induced dendritic spine loss.

Authors:  Nancy R Stallings; Melissa A O'Neal; Jie Hu; Ege T Kavalali; Ilya Bezprozvanny; James S Malter
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.